Clinical trial

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-12-15

PhaseN/A

Study timeline

Study start (actual)2023-12-15Date precision: day

Registry last updated2025-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinomaunresolved

Non-small Cell Lung Cancerunresolved

Interventions

Blood ctDNA + methylation + PET-CT and Postoperative pathologyPROCEDURE

MRD+ methylation (or combined with PET-CT) and Invasive mediastinoscopy /EBUS-TBNAPROCEDURE

Intraoperative lymph node dissectionPROCEDURE

Sponsors & collaborators

Shanghai Chest Hospitallead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06358222 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.